University of Miami Health System, Sylvester Comprehensive Cancer Center | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
University Of Miami Health System, Sylvester Comprehensive Cancer Center

University of Miami Health System, Sylvester Comprehensive Cancer Center

1475 NW 12th Ave 1st Floor
Miami, Florida, United States
Phone   Web  

Amyloidosis is a rare protein deposition disease. It is caused by amyloid, an abnormal protein that can build up in body tissue or organs. When amyloid protein deposits increase, it interferes with function and may cause organ failure. Systemic amyloidosis is the most common. Although amyloidosis is not cancer, it may be associated with blood cancers like multiple myeloma.

Sylvester specialists see the most cases of amyloidosis in Florida and have investigator-initiated clinical trials and a large amyloid support group. Amyloidosis can affect many organs and lead to multiple organ failures. Treatment here is handled by a collaborative multi-disciplinary team. The multidisciplinary team includes hematologic oncologists, cardiologists and cardiac and liver transplant specialists. As members of the National Consortium of Amyloid Trial Centers, your Sylvester specialist has access to even more clinical trials.

One program unique to Sylvester is an amyloid early detection program. We screen people with carpal tunnel syndrome for amyloidosis. The syndrome can be an early sign of amyloidosis. That allows us to pick up the disease early and start treatment, making for a better prognosis. 

The team includes healthcare professionals in the following areas:

Hematology and Oncology:
James Edward Hoffman, MD

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close